On Demand Webinar: Preventing diabetes with intentional weight loss
In this first of a series of three webinars focussing on obesity, hosted by ABCD and GIRFT and supported by Novo Nordisk Ltd, Professor Carel le Roux will present strategies for preventing diabetes with intentional weight loss.
This is a Novo Nordisk Sponsored meeting
Novo Nordisk has provided sponsorship to the Association of British Clinical Diabetologists (ABCD) to fully fund all costs for the development and delivery of this webinar, including creation, administration, promotion and speaker honoraria. Novo Nordisk has had no influence on the content and full editorial control remains the sole responsibility of ABCD.
Related Event
Preventing diabetes with intentional weight loss
Speakers
-
Professor Carel le Roux
Professor Carel le Roux graduated from medical school in Pretoria South Africa, completed his specialist training in metabolic medicine at St Bartholomew’s Hospitals and the Hammersmith Hospitals. He obtained his PhD from Imperial College London where he later took up a faculty position. He moved to University College Dublin for the Chair in Experimental Pathology and he is now a Director of the Metabolic Medicine Group. He also holds the position of Professor of Metabolic Medicine at Ulster University. He currently coordinates an Innovative Medicine Initiative project on obesity. He previously received a President of Ireland Young Researcher Award, Irish Research Council Laurate Award, Clinician Scientist Award from the National Institute Health Research in the UK, and a Wellcome Trust Clinical Research Fellowship for his work on how the gut talks to the brain. -
Dr. Abd Tahrani
Abd Tahrani is currently the International Medical Vice President, Obesity & NASH, Clinical Drug Development, Novo Nordisk in Copenhagen. He is also an honorary Senior Lecturer in Metabolic Endocrinology and Obesity Medicine at the University of Birmingham (UoB) and an Honorary Consultant in Endocrinology, Diabetes & Weight Management at the University Hospitals Birmingham NHS Foundation Trust.
Prior to joining Novo Nordisk, he was the lead for translational research in the Centre of Endocrinology, Diabetes and Metabolism (CEDAM), Birmingham Health Partners and the chair of the clinical committee of the Association for the Study of Obesity (ASO) UK. Abd is currently an associate editor for the European Journal of Endocrinology and the chair of the Type 2 Diabetes Research Steering Group in Diabetes UK and a member of the nutrition and obesity group of the ESE.
Abd received several awards including NIHR research training fellowship (2008), NIHR Clinician Scientist (2012), the American Academy of Sleep Medicine Young investigator award in OSA research (2013), and SCOPE National & International Fellowships from the World Obesity Federation in (2014 & 2020). Abd’s research themes included: 1) the metabolic consequences of sleep-related disorders, 2) obesity management & health care delivery, 3) diabetes-related neuropathy.
Abd has published over 170 peer reviewed articles and delivered more than 110 invited talks in the leading conferences globally. Abd held a number of positions before joining Novo Nordisk including being a trustee of ASO (UK), a panel member of the British Sleep Society Research Committee, an Expert advisor to NICE technology appraisals in obesity and neuropathy, a member of the Obesity Policy Engagement Network (OPEN) UK and a member of the strategic council of the Obesity All Party Parliamentary Group (Obesity APPG). He is a regular peer reviewer to the leading journals and research funding organisations. Till recently he was a senior editor for BMC Endocrine Disorders.
